Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Nolan

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Clinical Pharmacy|June 1, 1988
Thrombolysis for acute myocardial infarction: does a greater incidence of reperfusion justify preferential use of an agent?P E Nolan
The American Journal of Cardiology|December 1, 1989
Generic substitution of antiarrhythmic drugsP E Nolan
Pharmacotherapy|March 1, 1997
Pharmacokinetics and pharmacodynamics of intravenous agents for ventricular arrhythmiasP E Nolan
Critical Care Clinics|July 11, 1991
Toxic effects of drugs used in the ICU. Antiarrhythmic agentsP E Nolan, C L Raehl
Urology|February 1, 1986
Chronic bacterial prostatitis: problems in diagnosis and therapyG W Drach, P E Nolan
DICP : the Annals of Pharmacotherapy|February 1, 1989
Precipitation of benzodiazepine withdrawal following sudden discontinuation of midazolamP R Finley, P E Nolan
Chest|November 1, 1988
New drugs for treating lung infectionP E Nolan, J B Bass
Drug Safety|January 6, 2001
Antiarrhythmic agents: drug interactions of clinical significanceT C Trujillo, P E Nolan
The Journal of Infection|September 8, 2001
Cellulitis and bacteraemia due to Chryseobacterium indologenesB T Green, P E Nolan
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 24, 1998
Unfractionated heparin in acute coronary syndromes: has its time come and gone?T C Trujillo, P E Nolan
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Clinical Pharmacy|June 1, 1988
Thrombolysis for acute myocardial infarction: does a greater incidence of reperfusion justify preferential use of an agent?P E Nolan
The American Journal of Cardiology|December 1, 1989
Generic substitution of antiarrhythmic drugsP E Nolan
Pharmacotherapy|March 1, 1997
Pharmacokinetics and pharmacodynamics of intravenous agents for ventricular arrhythmiasP E Nolan
Critical Care Clinics|July 11, 1991
Toxic effects of drugs used in the ICU. Antiarrhythmic agentsP E Nolan, C L Raehl
Urology|February 1, 1986
Chronic bacterial prostatitis: problems in diagnosis and therapyG W Drach, P E Nolan
DICP : the Annals of Pharmacotherapy|February 1, 1989
Precipitation of benzodiazepine withdrawal following sudden discontinuation of midazolamP R Finley, P E Nolan
Chest|November 1, 1988
New drugs for treating lung infectionP E Nolan, J B Bass
Drug Safety|January 6, 2001
Antiarrhythmic agents: drug interactions of clinical significanceT C Trujillo, P E Nolan
The Journal of Infection|September 8, 2001
Cellulitis and bacteraemia due to Chryseobacterium indologenesB T Green, P E Nolan
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 24, 1998
Unfractionated heparin in acute coronary syndromes: has its time come and gone?T C Trujillo, P E Nolan
Pageof 4